We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.44B
AUM Growth
+$5.13M
Cap. Flow
-$60.9M
Cap. Flow %
-1.77%
Top 10 Hldgs %
13.68%
Holding
1,403
New
134
Increased
468
Reduced
577
Closed
124

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$7.91M
2
SBUX icon
Starbucks
SBUX
+$6.48M
3
CVS icon
CVS Health
CVS
+$6M
4
MDT icon
Medtronic
MDT
+$5.54M
5
WMT icon
Walmart Inc
WMT
+$5.12M

Sector Composition

Rank Sector Weight
1 Healthcare 12.56%
2 Financials 11.38%
3 Technology 10.34%
4 Industrials 9.82%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FVD icon
851
First Trust Value Line Dividend Fund
FVD
$8.32B
$437K 0.01%
15,604
-29,449
-65% -$802K
LL
852
DELISTED
LL Flooring Holdings, Inc.
LL
$437K 0.01%
27,786
-1,720
-6% -$30K
FSD
853
DELISTED
FIRST TRUST HIGH INCOME LONG/SHORT FUND
FSD
$436K 0.01%
27,109
+1,836
+7% +$28.6K
HQL
854
abrdn Life Sciences Investors
HQL
$581M
$435K 0.01%
25,607
+748
+3% +$13.1K
HPQ icon
855
HP
HPQ
$24.9B
$432K 0.01%
29,105
+1,636
+6% +$24.8K
SPGI icon
856
S&P Global
SPGI
$121B
$432K 0.01%
4,014
XLB icon
857
State Street Materials Select Sector SPDR ETF
XLB
$8.5B
$426K 0.01%
17,158
+8,300
+94% +$201K
FFA
858
First Trust Enhanced Equity Income Fund
FFA
$450M
$425K 0.01%
31,438
+2,741
+10% +$36.8K
AX icon
859
Axos Financial
AX
$5.77B
$424K 0.01%
+14,850
New +$354K
TSEM icon
860
Tower Semiconductor
TSEM
$24.8B
$424K 0.01%
+22,300
New +$385K
DNR
861
DELISTED
Denbury Resources, Inc.
DNR
$424K 0.01%
115,249
-5,800
-5% -$18.6K
TSLF
862
DELISTED
THL CREDIT SENIOR LOAN FUND
TSLF
$422K 0.01%
22,500
-3,000
-12% -$50.9K
CAH icon
863
Cardinal Health
CAH
$53.9B
$420K 0.01%
5,826
-102
-2% -$7.37K
LPX icon
864
Louisiana-Pacific
LPX
$5.06B
$420K 0.01%
22,200
-10,500
-32% -$200K
VCIT icon
865
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
$420K 0.01%
4,897
-135
-3% -$11.7K
IAU icon
866
iShares Gold Trust
IAU
$62.9B
$419K 0.01%
18,924
-94,928
-83% -$2.23M
ISRG icon
867
Intuitive Surgical
ISRG
$127B
$419K 0.01%
5,940
+2,187
+58% +$161K
SBY
868
DELISTED
Silver Bay Realty Trust Corp.
SBY
$419K 0.01%
24,431
XEL icon
869
Xcel Energy
XEL
$48.8B
$418K 0.01%
10,290
-717
-7% -$28.7K
BUFF
870
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
$418K 0.01%
+17,396
New +$421K
CLDX icon
871
Celldex Therapeutics
CLDX
$2.99B
$417K 0.01%
7,839
-1,300
-14% -$74K
BKT icon
872
BlackRock Income Trust
BKT
$330M
$416K 0.01%
21,925
-900
-4% -$17.1K
BCV
873
Bancroft Fund
BCV
$133M
$415K 0.01%
20,516
-10,010
-33% -$204K
BRKL
874
DELISTED
Brookline Bancorp
BRKL
$414K 0.01%
25,227
-7,573
-23% -$108K
AA icon
875
Alcoa
AA
$11.9B
$412K 0.01%
14,685
-89,801
-86% -$2.44M

Similar funds

Oppenheimer & Co's Q4 2016 Portfolio in Review

As of Q4 2016, Oppenheimer & Co held 1,403 positions worth $3.44B, up 0.15% from $3.43B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q4 2016 filing shows 134 new, 468 increased, 577 reduced and 124 closed positions. Its largest new stake was Yum China: 126,647 shares worth $3.31M. The largest sale was Bank of America, an estimated $7.91M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Financials and Technology.

  • Oppenheimer & Co's largest Q4 2016 buy was Yum China: 126,647 shares worth $3.31M.
  • Oppenheimer & Co added most to Lumen in Q4 2016, an estimated $7.38M increase.
  • Oppenheimer & Co's biggest Q4 2016 reduction was Bank of America, cutting an estimated $7.91M.
  • Oppenheimer & Co fully exited iShares MBS ETF in Q4 2016, selling an estimated $3.35M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.44B portfolio in Q4 2016.
  • Oppenheimer & Co opened 134 new positions and closed 124 in Q4 2016.
  • Oppenheimer & Co's portfolio value rose 0.15% quarter-over-quarter to $3.44B.

Based on Oppenheimer & Co's 13F filing for Q4 2016, filed 2 Feb 2017.